BRIGHT VISION ACQUISITION CORP. New York, NY 10017Securities Subscription Agreement • August 3rd, 2021 • Deep Medicine Acquisition Corp. • Blank checks • New York
This agreement (the “Agreement”) is entered into on March 15, 2021 by and between Bright Vision Sponsor LLC, a Delaware limited liability company (the “Subscriber” or “you”), and Bright Vision Acquisition Corp., a Delaware corporation (the “Company”, “we” or “us”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 2,875,000 shares of Class B common stock, $0.0001 par value per share (the “Shares”), up to 375,000 of which are subject to forfeiture by you if the underwriters of the initial public offering (“IPO”) of units (“Units”) of the Company, do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company and the Subscriber’s agreements regarding such Shares are as follows:
RIGHTS AGREEMENTRights Agreement • August 3rd, 2021 • Deep Medicine Acquisition Corp. • Blank checks • New York
This Rights Agreement (this “Agreement”) is made as of [______], 2021 by and between Deep Medicine Acquisition Corp., a Delaware company with offices at 595 Madison Avenue, 12th Floor, New York, NY 10017 (the “Company”) and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, with offices at 6201 15th Avenue, Brooklyn, NY 11219 (“Rights Agent”).
